Acknowledgement
Supported by : 이대목동병원
References
- Cowie M, Mendez G. BNP and congestive heart failure. Curr Probl Cardiol 2003;44:264-310
- Cowie M, Jourdain P, Maisel A, Dahlstrom U, Follath F, Isnard R, et al. Clinical applications of B-type natriuretic peptide(BNP) testing. Eur Heart J 2003;24:1710-18 https://doi.org/10.1016/S0195-668X(03)00476-7
- Groenning BA, Nilsson JC, Sondergaard L, Kjaer A, Larsson HB, Hildebrandt PR. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail 2001;3:699-708 https://doi.org/10.1016/S1388-9842(01)00181-7
- Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;323:757-8 https://doi.org/10.1056/NEJM199009133231114
- Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 2004;6:289-93 https://doi.org/10.1016/j.ejheart.2003.12.012
- Hall C. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004;6:257-60 https://doi.org/10.1016/j.ejheart.2003.12.015
- Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease. Circulation 2004; 110:2747-71 https://doi.org/10.1161/01.CIR.0000145143.19711.78
- Rowley AH. Incomplete (atypical) Kawasaki disease. Pediatr Infect Dis J 2002;21:563-5 https://doi.org/10.1097/00006454-200206000-00015
- Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, 1984
- Peduzzi TL, Pitetti RD. Myocardial infarction and atypical Kawasaki disease in a 3-month-old infant. Pediatr Emerg Care 2002;18:16-9 https://doi.org/10.1097/00006565-200210000-00008
- Kawamura T, Masakuni W, Kawaguchi H, Tahara M, Yuge M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr Int 2000;42:241-8 https://doi.org/10.1046/j.1442-200x.2000.01225.x
- Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993;88:82-91 https://doi.org/10.1161/01.CIR.88.1.82
- Ma KK, Ogawa T, de Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 2004;36:505-13 https://doi.org/10.1016/j.yjmcc.2004.01.001
- Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K, et al. Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 1996;155: 291-6 https://doi.org/10.1007/BF02002715
- Sato N, Sagawa K, Sasaguri Y, Inoue O, Kato H. Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease. J Pediatr 1993;122:198-203 https://doi.org/10.1016/S0022-3476(06)80113-7
- Maury CPJ, Salo E, Pelkonen P. Circulating interleukin- 1beta in patients with Kawasaki disease. N Engl J Med 1988;319:1670-1 https://doi.org/10.1056/NEJM198812223192515
- Kawamura T, Wago M. Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease. Cardiol Young 2002;12:153-8 https://doi.org/10.1017/S1047951102000318
- Harada E, Nakagawa O, Yoshimura M, Harada M, Nakagawa M, Mizuno Y, et al. Effect of interleukin-1beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture. J Mol Cell Cardiol 1999;31:1997-2006 https://doi.org/10.1006/jmcc.1999.1030
- Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein AJ. N-terminal pro-B-type natriuretic peptide : reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart disease. Acta Paediatr 2004;93:603-7 https://doi.org/10.1080/08035250410025799
- Mir TS, Marohn S, Laer S, Eiselt M, Grollmus O, Weil J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002;110:e76 https://doi.org/10.1542/peds.110.6.e76
- Rowley AH, Shulman ST. Kawasaki disease. In : Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th ed. Philadelphia : WB Saunders Co, 2004: 823-6
- Takahashi M. Kawasaki syndrome(mucocutaneous lymph node syndrome). In : Allen HD, Gutgesell HD, Clark EB, Driscoll DJ, editors. Moss and Adams' heart disease in infants, children, and adolescents including the fetus and young adults. 6th ed. Philadelphia : Lippincott Williams & Wilkins Co, 2001:1216-25
- Nakagawa O, Ogawa Y, Hiroshi I, Suga S, Komatsu Y, Kishimoto I, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-7 https://doi.org/10.1172/JCI118162
- Hunt PJ, Yandle TG, Nicholls MG, Richards AM, Espiner EA. The amino-terminal portion of pro-brain natriuretic peptide(Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995;214:1175-83 https://doi.org/10.1006/bbrc.1995.2410
- de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362: 316-22 https://doi.org/10.1016/S0140-6736(03)13976-1
- Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80 https://doi.org/10.1161/01.CIR.87.5.1776
- Cardarelli R, Lumicao TG Jr. B-type natriuretic peptide : A review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians. J Am Board Fam Pract 2003;16:327-33 https://doi.org/10.3122/jabfm.16.4.327
- Bonow RO. New insights into the cardiac natriuretic peptides. Circulation 1996;93:1946-50 https://doi.org/10.1161/01.CIR.93.11.1946
- Rauh M, Koch A. Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children. Clin Chem 2003;49:1563-4 https://doi.org/10.1373/49.9.1563